Advertisement

Topics

Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017

15:36 EST 1 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Click to Tweet Flex Pharma, Inc. (NASDAQ: FLKS), a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ...

Other Sources for this Article

Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
SVP, Investor Relations & Corporate Communications
irdept@flex-pharma.com

NEXT ARTICLE

More From BioPortfolio on "Flex Pharma to Report Fourth Quarter and Full Year 2016 Results on March 8, 2017"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...